Report overview
This report contains market size and forecasts of Peptic Ulcer Drugs in Global, including the following market information:
Global Peptic Ulcer Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Peptic Ulcer Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Proton Pump Inhibitors Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Peptic Ulcer Drugs include AstraZeneca, Livzon Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, CTTQ, Luoxin Pharmaceuticals, Takeda, Eisai, Jumpcan Pharmaceutical and Zhejiang Conba Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptic Ulcer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptic Ulcer Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Peptic Ulcer Drugs Market Segment Percentages, by Type, 2022 (%)
Proton Pump Inhibitors
Antacids
H2-Receptor Antagonists
Others
Global Peptic Ulcer Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Peptic Ulcer Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital and Clinic
Pharmacy
Global Peptic Ulcer Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptic Ulcer Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptic Ulcer Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Livzon Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
CTTQ
Luoxin Pharmaceuticals
Takeda
Eisai
Jumpcan Pharmaceutical
Zhejiang Conba Pharmaceutical
Youcare Pharmaceutical
Chongqing Lummy Pharmaceutical
Huadong Medicine
Hansoh Pharmaceutical
CR Double-Crane
Hunan Warrant Pharmaceutical
Changzhou Siyao Pharmaceuticals
Chongqing Pharscin Pharmaceutical
Lionco Pharmaceutical
Jiangsu Wuzhong Pharmaceutical
Cisen Pharmaceutical
